AIDS 2014


The International AIDS Conference is the largest conference on HIV/AIDS and gathers thousands of people from around the world. This year’s conference, nicknamed “AIDS 2014,” happens July 20–25 in Melbourne, Australia. 

San Francisco AIDS Foundation will have a strong presence at this gathering of top thought leaders in the HIV field,  including poster presentations, two late-breaker sessions and a special free community event to discuss gay men's health and PrEP, co-hosted by the Victorian AIDS Council.

See all our events, or keep up with us during the conference via Twitter - @sfaidsfound


AIDS 2014 Conference Coverage on BETA

As always, you can get the latest on HIV research at BETA Blog, including coverage of AIDS 2014.

Below are the most recent conference-related stories:

AIDS 2014 Recap: Meeting the Needs of Transgender Women

AIDS 2014 Recap: Meeting the Needs of Transgender Women

Transgender women are among the most marginalized and HIV-affected groups worldwide. HIV prevalence estimates range widely, largely because data on transgender populations around the globe are incomplete, but a recent … Read More

AIDS 2014: Untangling HIV and Aging

AIDS 2014: Untangling HIV and Aging

As people with HIV live longer, issues of aging are gaining more attention from HIV/AIDS researchers, clinicians, and advocates. Although by no means a focus of AIDS 2014, HIV and … Read More

HIV Prevention Tops the News at AIDS 2014

HIV Prevention Tops the News at AIDS 2014

Biomedical prevention has garnered more headlines than HIV treatment in recent years, and the news coming out of the 20th International AIDS Conference last week in Melbourne was no exception. … Read More

Hepatitis C Now a Theme at International AIDS Conference

Hepatitis C Now a Theme at International AIDS Conference

Given the advent of effective new treatments, hepatitis C was a major topic at the 20th International AIDS Conference held last week in Melbourne, Australia. An estimated 150 to 200 … Read More

No Link Between Efavirenz and Neurocognitive Impairment in Italian Study

No Link Between Efavirenz and Neurocognitive Impairment in Italian Study

The widely used antiretroviral drug efavirenz was not linked with neurocognitive impairment in a study reported this week at AIDS 2014. Efavirenz (Sustiva, also part of the popular Atripla combo … Read More

HIV Trends in San Francisco and London: An AIDS 2014 Q&A

HIV Trends in San Francisco and London: An AIDS 2014 Q&A

At AIDS 2014, underway this week in Melbourne, Australia, thousands of researchers, advocates, policymakers, and community members are gathered to learn the latest in HIV science and policy—and, importantly, to … Read More

Twenty-Plus Positive Years: An AIDS Survivor Dialogue in Melbourne

Twenty-Plus Positive Years: An AIDS Survivor Dialogue in Melbourne

An afternoon session, titled “Twenty Plus Positive Dialogues: People Who Have Lived with HIV for 20 Years or More,” on July 22 at the International AIDS Conference Global Village featured … Read More

AIDS 2014: Videos, Webcasts, and Tweets, Oh My!

AIDS 2014: Videos, Webcasts, and Tweets, Oh My!

AIDS 2014 is in full swing, with HIV cure prospects and breaking news on PrEP among the conference’s major developments. (Click here to see all of BETA’s AIDS 2014 coverage.) … Read More

Setbacks and Progress in the Search for an HIV Cure

Setbacks and Progress in the Search for an HIV Cure

The quest for a cure for HIV has been one of the themes at the 20th International AIDS Conference (AIDS 2014) taking place this week in Melbourne, with scientists reporting … Read More

PrEP Works Despite Missed Doses, Although Daily Use Is Advised

PrEP Works Despite Missed Doses, Although Daily Use Is Advised

No one who took Truvada PrEP at least four times per week acquired HIV in the iPrEx Open Label Extension (iPrEx OLE) demonstration project, according to data presented today at … Read More

Sign up for BETA

Sign up here to get BETA in your email inbox.
   Please leave this field empty
 

Join us on Twitter